In Vitro Activities of Doripenem and Six Comparator Drugs against 423 Aerobic and Anaerobic Bacterial Isolates from Infected Diabetic Foot Wounds-Reference-Cited by-同舟云学术

In Vitro Activities of Doripenem and Six Comparator Drugs against 423 Aerobic and Anaerobic Bacterial Isolates from Infected Diabetic Foot Wounds

Published:2008-02 Issue:2 Volume:52 Page:761-766
ISSN:0066-4804
Container-title:Antimicrobial Agents and Chemotherapy
language:en
Short-container-title:Antimicrob Agents Chemother

Author:

Goldstein Ellie J. C.¹²,Citron Diane M.¹,Merriam C. Vreni¹,Warren Yumi A.¹,Tyrrell Kerin L.¹,Fernandez Helen T.¹

Affiliation:

1. R M Alden Research Laboratory, Santa Monica, California 90404

2. UCLA School of Medicine, Los Angeles, California 90095

Abstract

ABSTRACT Against 182 anaerobe and 241 aerobe strains obtained from diabetic foot infections, doripenem was the most active carbapenem against Pseudomonas aeruginosa (MIC 90 , 2 μg/ml), more active than imipenem against Proteus mirabilis , and ertapenem was more active against Escherichia coli and Klebsiella spp. The MIC 50 and MIC 90 values were ≤0.125 μg/ml for methicillin-sensitive Staphylococcus aureus and all streptococci and 0.25/1 for Bacteroides fragilis .

Publisher

American Society for Microbiology

Subject

Infectious Diseases,Pharmacology (medical),Pharmacology

Link

https://journals.asm.org/doi/pdf/10.1128/AAC.01128-07

Reference19 articles.

1. Anderson, D. L. 2006. Doripenem. Drugs Today42:399-404.

2. Anonymous. 2003. Doripenem: S 4661. Drugs R. D.4:363-365.

3. National diabetes fact sheet. 2005

4. Bacteriology of Moderate-to-Severe Diabetic Foot Infections and In Vitro Activity of Antimicrobial Agents

5. Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically; approved standard 2003

Cited by 34 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Research Progress in Bacteroides Resistance to Carbapenems and Their Resistance Mechanism;Advances in Clinical Medicine;2023

2. Carbapenem resistance in Bacteroides fragilis: A review of molecular mechanisms;Anaerobe;2022-08

3. Nanotechnology and Diabetic Foot Ulcer: Future Prospects;Diabetic Foot Ulcer;2020-10-06

4. Pharmacokinetic modeling and simulation for dose rationale of doripenem in neonates and infants;Drug Metabolism and Pharmacokinetics;2020-02

5. Population Pharmacokinetics of Doripenem in Pediatric Patients and Monte-Carlo Pharmacokinetic-Pharmacodynamic Simulations for Dosing Regimen Assessment;Journal of Pharmaceutical Sciences;2019-09